Overview

Phase II Safety and Efficacy Study of Oral ORMD-0801 in Patients With Type 2 Diabetes Mellitus

Status:
Completed
Trial end date:
2016-09-13
Target enrollment:
Participant gender:
Summary
Randomized, double-blind, placebo-controlled, parallel group study.
Phase:
Phase 2
Details
Lead Sponsor:
Oramed, Ltd.
Collaborator:
Integrium
Treatments:
Insulin
Insulin, Globin Zinc
Metformin